vs

Side-by-side financial comparison of Mid-America Apartment Communities (MAA) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $553.7M, roughly 1.1× Mid-America Apartment Communities). On growth, Mid-America Apartment Communities posted the faster year-over-year revenue change (438.7% vs 4.8%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs 0.7%).

Mid-America Apartment Communities, Inc. (MAA) is a publicly traded real estate investment trust based in Memphis, Tennessee that invests in apartments in the Southeastern United States and the Southwestern United States.

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

MAA vs RPRX — Head-to-Head

Bigger by revenue
RPRX
RPRX
1.1× larger
RPRX
$622.0M
$553.7M
MAA
Growing faster (revenue YoY)
MAA
MAA
+433.9% gap
MAA
438.7%
4.8%
RPRX
Faster 2-yr revenue CAGR
RPRX
RPRX
Annualised
RPRX
4.6%
0.7%
MAA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
MAA
MAA
RPRX
RPRX
Revenue
$553.7M
$622.0M
Net Profit
$214.2M
Gross Margin
Operating Margin
62.4%
Net Margin
34.4%
Revenue YoY
438.7%
4.8%
Net Profit YoY
2.9%
EPS (diluted)
$4.34
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MAA
MAA
RPRX
RPRX
Q1 26
$553.7M
Q4 25
$555.6M
$622.0M
Q3 25
$554.4M
$609.3M
Q2 25
$549.9M
$578.7M
Q1 25
$549.3M
$568.2M
Q4 24
$549.8M
$593.6M
Q3 24
$551.1M
$564.7M
Q2 24
$546.4M
$537.3M
Net Profit
MAA
MAA
RPRX
RPRX
Q1 26
Q4 25
$57.6M
$214.2M
Q3 25
$99.5M
$288.2M
Q2 25
$108.1M
$30.2M
Q1 25
$181.7M
$238.3M
Q4 24
$166.6M
$208.2M
Q3 24
$115.2M
$544.0M
Q2 24
$102.0M
$102.0M
Operating Margin
MAA
MAA
RPRX
RPRX
Q1 26
Q4 25
10.4%
62.4%
Q3 25
18.7%
70.1%
Q2 25
20.2%
36.3%
Q1 25
34.0%
94.0%
Q4 24
31.3%
60.9%
Q3 24
21.5%
Q2 24
19.3%
50.2%
Net Margin
MAA
MAA
RPRX
RPRX
Q1 26
Q4 25
10.4%
34.4%
Q3 25
18.0%
47.3%
Q2 25
19.7%
5.2%
Q1 25
33.1%
41.9%
Q4 24
30.3%
35.1%
Q3 24
20.9%
96.3%
Q2 24
18.7%
19.0%
EPS (diluted)
MAA
MAA
RPRX
RPRX
Q1 26
$4.34
Q4 25
$0.48
$0.49
Q3 25
$0.84
$0.67
Q2 25
$0.92
$0.07
Q1 25
$1.54
$0.55
Q4 24
$1.43
$0.46
Q3 24
$0.98
$1.21
Q2 24
$0.86
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MAA
MAA
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$618.7M
Total DebtLower is stronger
$9.0B
Stockholders' EquityBook value
$9.7B
Total Assets
$19.6B
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MAA
MAA
RPRX
RPRX
Q1 26
Q4 25
$60.3M
$618.7M
Q3 25
$32.2M
$938.9M
Q2 25
$54.5M
$631.9M
Q1 25
$55.8M
$1.1B
Q4 24
$43.0M
$929.0M
Q3 24
$50.2M
$950.1M
Q2 24
$62.8M
$1.8B
Total Debt
MAA
MAA
RPRX
RPRX
Q1 26
Q4 25
$9.0B
Q3 25
$8.9B
Q2 25
$8.0B
Q1 25
$7.6B
Q4 24
$7.6B
Q3 24
$7.6B
Q2 24
$7.6B
Stockholders' Equity
MAA
MAA
RPRX
RPRX
Q1 26
Q4 25
$5.7B
$9.7B
Q3 25
$5.8B
$9.6B
Q2 25
$5.9B
$9.5B
Q1 25
$5.9B
$9.8B
Q4 24
$5.9B
$10.3B
Q3 24
$5.9B
$10.3B
Q2 24
$6.0B
$9.8B
Total Assets
MAA
MAA
RPRX
RPRX
Q1 26
Q4 25
$12.0B
$19.6B
Q3 25
$11.9B
$19.3B
Q2 25
$11.8B
$18.3B
Q1 25
$11.8B
$17.6B
Q4 24
$11.8B
$18.2B
Q3 24
$11.8B
$18.0B
Q2 24
$11.6B
$17.7B
Debt / Equity
MAA
MAA
RPRX
RPRX
Q1 26
Q4 25
0.92×
Q3 25
0.93×
Q2 25
0.84×
Q1 25
0.78×
Q4 24
0.74×
Q3 24
0.74×
Q2 24
0.78×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MAA
MAA
RPRX
RPRX
Operating Cash FlowLast quarter
$827.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.86×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MAA
MAA
RPRX
RPRX
Q1 26
Q4 25
$261.7M
$827.1M
Q3 25
$266.4M
$702.6M
Q2 25
$353.4M
$364.0M
Q1 25
$196.6M
$596.1M
Q4 24
$239.1M
$742.5M
Q3 24
$309.5M
$703.6M
Q2 24
$349.4M
$658.2M
Free Cash Flow
MAA
MAA
RPRX
RPRX
Q1 26
Q4 25
$158.6M
Q3 25
$170.8M
Q2 25
$264.5M
Q1 25
$124.0M
Q4 24
$152.6M
Q3 24
$215.5M
Q2 24
$259.7M
FCF Margin
MAA
MAA
RPRX
RPRX
Q1 26
Q4 25
28.5%
Q3 25
30.8%
Q2 25
48.1%
Q1 25
22.6%
Q4 24
27.8%
Q3 24
39.1%
Q2 24
47.5%
Capex Intensity
MAA
MAA
RPRX
RPRX
Q1 26
Q4 25
18.6%
Q3 25
17.2%
Q2 25
16.2%
Q1 25
13.2%
Q4 24
15.7%
Q3 24
17.1%
Q2 24
16.4%
Cash Conversion
MAA
MAA
RPRX
RPRX
Q1 26
Q4 25
4.55×
3.86×
Q3 25
2.68×
2.44×
Q2 25
3.27×
12.06×
Q1 25
1.08×
2.50×
Q4 24
1.43×
3.57×
Q3 24
2.69×
1.29×
Q2 24
3.43×
6.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MAA
MAA

Same Store Communities$517.0M93%
Non-Same Store Communities$22.1M4%
Lease-up/Development Communities$7.7M1%
Commercial Property/Land$7.0M1%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons